Endpoints News
How the IRA helped Medicare members Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M T W Thu F
18 June, 2026
Manufacturing Day 2026
Biopharma has metabolized the tariff chaos, but the ground keeps shifting under manufacturing and supply chain teams. Hear directly from the experts on what’s changed, what’s working, and what to watch. Join us.
top stories
1. Exclusive: Treasury is assessing options to screen investments in China biotech
2. IRA's $2,000 out-of-pocket cap helped Medicare patients access expensive drugs, study finds
3. Exclusive: Lilly's TuneLab crosses 100-member mark, adds AI models from buzzy startup Chai
4. Biogen makes up to $1B deal for secretive anti-inflammatory biotech
5.
peer review
Moderna adds commercial chief, expands Stephen Hoge's role; Reunion Neuroscience CEO departs
6. Novocure’s electric fields therapy fails key glioblastoma study
7. Antifungal from F2G, Shionogi succeeds in Phase 3 study
8. Kardigan raises $400M in IPO to back three clinical-stage cardio drugs
more stories
 
Lydia Ramsey Pflanzer
.

We'll be off tomorrow to observe Juneteenth. See you Monday!

.
Lydia Ramsey Pflanzer
Deputy Editor, Endpoints News
Shutterstock
1
by Max Bayer

Of­fi­cials at the Trea­sury De­part­ment are look­ing at po­ten­tial re­stric­tions on US in­vest­ments in Chi­na biotech, ac­cord­ing to mul­ti­ple sources fa­mil­iar with the dis­cus­sions.

At...

Read the full story
2
by Zachary Brennan

Med­ica­tion us­age, par­tic­u­lar­ly for the most ex­pen­sive drugs, in­creased sig­nif­i­cant­ly short­ly af­ter the Medicare an­nu­al out-of-pock­et cost cap took ef­fect in Jan­u­ary 2025, a study...

Read the full story
The Endpoints 100: Despite all the turmoil, biotech is having a moment
A year ago, biotech was in its bleakest stretch in a decade. Now IPOs are rebounding and China deals are heating up. John Carroll and a panel of industry leaders dig into the latest Endpoints 100 results and uncover what’s next for the sector.
Aliza Apple, global head of Eli Lilly's TuneLab
3
by Andrew Dunn

The leader be­hind TuneLab, Eli Lil­ly's first-of-its-kind AI ini­tia­tive, had no idea what to ex­pect when it launched.

Lil­ly was try­ing some­thing new by ef­fec­tive­ly...

Read the full story
4
by Kyle LaHucik

Bio­gen will pay as much as $1 bil­lion — “pre­dom­i­nant­ly” in mile­stone pay­ments — to ac­quire a San Diego biotech that has dis­closed lit­tle about...

Read the full story
Peer Review: Weekly biopharma job report
5
by Alex Hoffman, Kyle LaHucik, Max Bayer

→ In prepa­ra­tion for po­ten­tial new prod­uct launch­es, Mod­er­na has se­lect­ed Es­ter Banque as chief com­mer­cial of­fi­cer and ex­pand­ed the role of pres­i­dent Stephen Hoge...

Read the full story
6
by Lei Lei Wu

Novo­cure